SM
SG3 Management Portfolio holdings
AUM
$6.45K
This Quarter Return
+0.93%
1 Year Return
-62.95%
3 Year Return
-60.35%
5 Year Return
-56.94%
10 Year Return
–
AUM
$235M
AUM Growth
+$235M
(-23%)
Cap. Flow
-$80.1M
Cap. Flow
% of AUM
-34.11%
Top 10 Holdings %
Top 10 Hldgs %
35.12%
Holding
862
New
116
Increased
55
Reduced
76
Closed
146
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$24.4M |
| 2 |
Moderna
MRNA
|
$9.14M |
| 3 |
Amgen
AMGN
|
$7.8M |
| 4 |
Pinduoduo
PDD
|
$5.6M |
| 5 |
Bank of America
BAC
|
$4.84M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$31M |
| 2 |
Biogen
BIIB
|
$8.77M |
| 3 |
Aon
AON
|
$6.33M |
| 4 |
Sunrun
RUN
|
$4.78M |
| 5 |
PARA
Paramount Global Class B
PARA
|
$4.73M |
Sector Composition
| 1 | Healthcare | 27.19% |
| 2 | Communication Services | 15.29% |
| 3 | Consumer Discretionary | 14.51% |
| 4 | Technology | 12.96% |
| 5 | Financials | 7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
COUP
101
DELISTED
Coupa Software Incorporated
COUP
| $524K | 0.02% |
+2,000
| New | +$524K |
|
102
Energy Transfer Partners
ET
$60.3B
| $505K | 0.02% |
+47,500
| New | +$505K |
|
103
Insmed
INSM
$30.3B
| $498K | 0.02% |
+17,500
| New | +$498K |
|
|
TVRD
104
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
| $492K | 0.02% |
957
+68
| +8% | +$35K |
|
|
STKL
105
SunOpta
STKL
$741M
| $490K | 0.02% |
40,000
-25,000
| -38% | -$306K |
|
|
XYZ
106
Block, Inc.
XYZ
$46.2B
| $488K | 0.02% |
2,000
-5,000
| -71% | -$1.22M |
|
107
Kinross Gold
KGC
$26.6B
| $483K | 0.02% |
76,000
| – | – |
|
108
Emerson Electric
EMR
$72.9B
| $481K | 0.02% |
5,000
+2,000
| +67% | +$192K |
|
109
Mastercard
MA
$536B
| $475K | 0.02% |
1,300
+900
| +225% | +$329K |
|
|
SGEN
110
DELISTED
Seagen Inc. Common Stock
SGEN
| $474K | 0.02% |
+3,000
| New | +$474K |
|
111
Dynatrace
DT
$15.1B
| $467K | 0.02% |
+8,000
| New | +$467K |
|
112
APA Corp
APA
$8.11B
| $465K | 0.02% |
21,500
-1,500
| -7% | -$32.4K |
|
113
iShares Semiconductor ETF
SOXX
$13.4B
| $454K | 0.02% |
3,000
+1,500
| +100% | +$227K |
|
114
Gilead Sciences
GILD
$140B
| $448K | 0.02% |
6,500
-8,600
| -57% | -$593K |
|
|
BPMC
115
DELISTED
Blueprint Medicines
BPMC
| $440K | 0.02% |
+5,000
| New | +$440K |
|
116
Sabre
SABR
$683M
| $437K | 0.02% |
35,000
+5,000
| +17% | +$62.4K |
|
|
PHX
117
DELISTED
PHX Minerals
PHX
| $433K | 0.02% |
+116,481
| New | +$433K |
|
|
BBBY
118
DELISTED
Bed Bath & Beyond Inc
BBBY
| $433K | 0.02% |
+13,000
| New | +$433K |
|
119
Novavax
NVAX
$1.2B
| $425K | 0.02% |
+2,000
| New | +$425K |
|
120
Las Vegas Sands
LVS
$38B
| $422K | 0.02% |
8,000
-4,500
| -36% | -$237K |
|
|
PRPB
121
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
| $408K | 0.01% |
41,300
-64,948
| -61% | -$642K |
|
122
RH
RH
$4.14B
| $407K | 0.01% |
600
-400
| -40% | -$271K |
|
|
CVET
123
DELISTED
Covetrus, Inc. Common Stock
CVET
| $405K | 0.01% |
15,000
+7,070
| +89% | +$191K |
|
124
Ultragenyx Pharmaceutical
RARE
$3.04B
| $381K | 0.01% |
+4,000
| New | +$381K |
|
125
Planet Fitness
PLNT
$8.55B
| $376K | 0.01% |
5,000
-20,000
| -80% | -$1.5M |
|